Wednesday, February 28, 2018

GENESIS HEALTHCARE, PIONEER OF GENETIC TEST SERVICE, RAISES 1.65 BILLION YEN NEWLY

TOKYO, Feb 27 (Bernama-AsiaNet) -- Genesis Healthcare Co., Japan's pioneer genetic testing and research company, has completed a third-party equity allocation to Rakuten, Inc. (TSE: 4755) and Omron Healthcare Co., Ltd. Genesis' Capital has increased to 3.78 billion yen, and Genesis' post-money valuation is approximately 42 billion yen (*1).

As the market leader in the genetic testing and research field in Japan, Genesis has actively pursued development of the Japanese scientific landscape through numerous R&D, product development, awareness raising via human resource development and advanced education, and genetic data translation into useful solutions. As of today, the company's Japanese genetic data platform exceeds 550,000 individuals, the largest in Japan and potentially in Asia. In 2018, Genesis aims to accumulate data of 1 million people, or 1% of the population in Japan.
http://mrem.bernama.com/viewsm.php?idm=31292

No comments:

Post a Comment